Chelation Therapy Fails to Improve Outcome in Heart Disease: The TACT2 Trial
In the TACT2 trial, chelation therapy reduced levels of lead in the blood but did not improve cardiovascular outcomes for adults with diabetes and a prior heart attack.
Does Lifelong Low LDL-Cholesterol (Genetic) Reduce Heart Risk? YES!
Importance There are genetic variants that are inherited at birth and are associated with significantly lower low-density lipoprotein cholesterol (LDL-C) concentrations for life. These genetic "experiments" permit asking the question whether a lifelong lower LDL-C lowers the risks of coronary heart disease (CHD) like heart attacks. I published data like this in 2012 and showed with my co-authors that there was a large reduction in the risk of CHD in those born with genetic variants leading to a lifelong low LDL-C. A new study using a large, multiracial prospective population adds to this data.
STUDY: This studied included participants from 5 National Heart, Lung, and Blood Institute (NHLBI) studies and the UK Biobank. NHLBI study participants aged 5 to 84 years were recruited between 1971 and 2002 across the US and underwent whole-genome sequencing. UK Biobank participants aged 40 to 69 years were recruited between 2006 and 2010 in the UK and underwent whole-exome sequencing. Data were analyzed from June 2021 to October 2022.
RESULTS Among 19 073 NHLBI participants in the USA, only 139 (0.7%) carried the genetic variation that was associated with 49 mg/dL lower LDL-C. Over a follow-up of 21.5 years, incident CHD was observed in 8.6% vs 16.0% of the "non-inherited" group, or a 50% favorable reduction in CHD.
Among 190 464 UK Biobank participants, 0.4% carried a favorable genetic pattern associated with 45 mg/dL lower LDL-C. Estimated CHD risk by age 75 years was 3.7% vs 7.0% in noncarriers, corresponding to a 50 % reduction in CHD.
CONCLUSIONS
Among 209 537 individuals in this study, 0.4% carried a favorable genetic variaton that was associated with less exposure to LDL-C over there whole life. There was a 49% lower risk of CHD. This supports the Cholesterol Hypothesis that lowering LDL-C throughout life using lifestyle, and if needed, supplements and medication, favor the avoidance of heart disease and heart events like heart attacks.
You Might Also Enjoy...
Why You Must Know Your Lipoprotein(a) Blood Level: A New Statement of the NLA
Data continue to accumulate from large, population-based studies indicating that elevated plasma Lp(a) is an important risk factor for atherosclerotic CVD and calcific aortic valve disease.
Are Viagra and Cialis Anti-Aging Agents? Two New Studies Say Yes
Viagra (sildenafil) and Cialis (tadalfil) are used for mainly erectile dysfunction but were originally developed as cardiovascular medications. There safety has been proven for years. Two new studies give a suggestion that they may be anti-aging agents to0
Can a Healthy Diet Slow Aging and Reduce Dementia Risk? New Data Says Yes
Adherence to a MIND diet is associated with a lower incidence of dementia and mortality in a new study.
The MIND diet is based on the Mediterranean and DASH diets, and emphasizes plant-based foods, fish and poultry, with little in the way of saturated fats
Can a Seaweed Combination Capsule Help Reverse Atherosclerosis?
The study suggests that rhamnan sulfate from Monostroma nitidum may provide a safe and effective intervention for reducing atherosclerotic plaque, and should be evaluated as an adjunct therapy for prevention and treatment of cardiovascular disease.
Why Heart Patients Must Have a Home Sleep Study: The Brain and the Heart
Sleep apnea, including obstructive sleep apnea and central sleep apnea, can affect people of all ages but, as the National Council on Aging notes (link above), it is most prevalent in middle-aged and older adults.